Methylation alterations in the promoter region of B4GALT1 may lead to aberrant gene silencing or overexpression, thereby influencing glycosylation patterns and tumor behavior in HNSCC. This evidence concerns the gene B4GALT1 and head and neck squamous cell carcinoma.